Automated description from the Alliance of Genome Resources
Predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II proximal promoter sequence-specific DNA binding activity; and identical protein binding activity. Predicted to be involved in negative regulation of vasculature development; positive regulation of transcription by RNA polymerase II; and positive regulation of vascular smooth muscle cell proliferation. Predicted to localize to the fibrillar center. Orthologous to human FOXJ2 (forkhead box J2).